Skip to content
Screener

TScan Therapeutics, Inc. TCRX Q4 2025 Annual earnings

Reported March 4, 2026 · Before market open

Revenue$2.6MBeat by $131.5K
EPS-$0.18Beat by $0.09
Revenue estimate$2.4M
EPS estimate-$0.27

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$459.0K
EPS estimate-$0.26

FAQ

When did TScan Therapeutics, Inc. report Q4 2025 earnings?
TScan Therapeutics, Inc. (TCRX) reported Q4 2025 earnings on March 4, 2026 before market open.
What were TScan Therapeutics, Inc.'s Q4 2025 revenue and EPS?
TScan Therapeutics, Inc. reported revenue of $2.6M and eps of $-0.18 for Q4 2025.
Did TScan Therapeutics, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $2.4M by $131.5K. EPS beat the consensus estimate of $-0.27 by $0.09.
How did TScan Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 286.0% from $665.0K a year earlier and eps grew 37.9% from $-0.29.
Where can I find TScan Therapeutics, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-089871) and the 10-K periodic report (0001193125-26-089884) directly on SEC EDGAR. The filing index links above go to sec.gov.